They came. We saw. They disrupted.
On Friday, I recapped our latest biotech event, “Boston’s Life Science Disruptors,” with some key takeaways from the stars of the show: Genocea Biosciences, Moderna Therapeutics, and Bluebird Bio (NASDAQ: BLUE). Today, as promised, I’ve circled back with a slideshow look at the festivities, including shots of the speakers, and you, our audience.
Again, big thanks to KeithSpiroPhoto courtesy of Kendall PRess for the pictures. Great thanks as well to our speakers, our event host, Novartis Institutes for Biomedical Research–and to our sponsors: BDO, Cubist, Health Advances, the Kauffman Foundation, and Mintz Levin.
Ben Fidler is Xconomy's Deputy Biotechnology Editor. You can e-mail him at email@example.com